Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine, 10/20/09
Lapperre TS et al. – This randomized trial compared treatment with fluticasone for 6 months, fluticasone for 30 months, fluticasone and salmeterol for 30 months, or placebo in steroid–naive patients who had COPD, most of whom had airway hyperresponsiveness. Investigators found reduced inflammatory cells in sputum and bronchial biopsies and attenuated decrease in lung function during fluticasone treatment. Adding salmeterol did not further alter the decrease in lung function. Steroids not only reduce inflammation but can also slow decrease in lung function in some subphenotypes of steroid–naive patients with COPD.
Related Articles
Parasternal muscle activity decreases in severe COPD with salmeterol-fluticasone propionate
Chest, 10/20/09
Relevance Score: 92%
Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes
COPD: Journal of Chronic Obstructive Pulmonary Disease, 10/06/09
Relevance Score: 92%
Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/07/09
Relevance Score: 90%
Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/05/09
Relevance Score: 90%
The immediate effect of individual manipulation techniques on pulmonary function measures in persons with chronic obstructive pulmonary disease
Internet Source, 10/09/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combination therapy of statins and fibrates in the management of cardiovascular risk
Current Opinion in Lipidology, 12/15/09
Polypill: the evidence and the promise
Current Opinion in Lipidology, 12/15/09
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/15/09
Today in Pulmonology...keeping you current
Receive free subspecialty "5-minute updates" via email
Respiratory function in an ageing population
Reviews in Clinical Gerontology, 12/15/09
Soft palate length and upper airway relationship in OSA and non-OSA subjects
Sleep and Breathing, 12/15/09
Ventilation and oxygen: cumulative effects of oxygen on ventilation induced lung injury
Pediatric Research, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


